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Abstract
Neonicotinoid insecticides are widely used replacements for organophosphate and carbamate 
insecticides, but the extent of human exposure is largely unknown. On the other hand, based on 
urinary concentrations of DEET metabolites, human exposure to N,N-diethyl-m-toluamide 
(DEET) appears to be widespread. We developed a fast online solid-phase extraction high-
performance liquid chromatography-isotope dilution tandem mass spectrometry (HPLC-MS/MS) 
method to measure in 200 μL of human urine the concentrations of six neonicotinoid biomarkers 
(acetamiprid, N-desmethyl-acetamiprid, clothianidin, imidacloprid, 5-hydroxy-imidacloprid, 
thiacloprid), and two DEET biomarkers (3-diethyl-carbamoyl benzoic acid, 3-ethyl-carbamoyl 
benzoic acid). Limits of detection ranged from 0.01 to 0.1 μg/L, depending on the biomarker. 
Accuracy ranged from 91 to 116% and precision ranged from 3.7 to 10 %RSD. The presented 
method can be used to increase our understanding of exposure to neonicotinoid insecticides and 
DEET, and to evaluate the potential health effects from such exposures.
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Introduction
Pesticides include a wide variety of products such as fungicides, herbicides, insecticides, and 
insect repellents. Neonicotinoid insecticides are used as agricultural insecticides [1–4] and 
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are also quite effective for flea control in cats and dogs [5]. In 2014, neonicotinoids 
dominated more than 25% of the insecticide market [6], although geographic differences 
may exist. For example, in 2012, sales in Latin America, Asia, and North America 
accounted for 75% of the global market, while sales in Europe only accounted for 11% [6]. 
Neonicotinoids have chemical structures similar to nicotine and target the insect’s nicotinic 
acetylcholine receptors (nAChRs) exciting the nerve cells, causing trembling and shaking, 
paralysis [7], and even death [2, 8]. The neonicotinoid family includes acetamiprid, 
clothianidin, imidacloprid, nitenpyram, nithiazine, thiacloprid, and thiamethoxam [9]; in 
2009, imidacloprid was the world’s top selling insecticide [3].
Neonicotinoids are persistent in the environment and have been detected in food, streams, 
and other environmental matrices [10, 11]. Neonicotinoids are used for growing genetically 
modified corn, soybeans, cotton, sunflowers, and canola, as well as various other genetically 
modified and non-genetically modified vegetables and fruits [12]. Approximately 90% of 
the corn and 50% of the soybeans planted in the USA have been treated with neonicotinoids 
[1]. Neonicotinoids are systemic in nature: their relatively high water solubility readily 
facilitates absorption through roots and leaves and distribution to all plant tissues, meaning 
neonicotinoids are not easily washed off food [5, 10]. Imidacloprid was detected in about 
70% of fruits and vegetables procured in 2012 from Boston neighborhood grocery stores; 
several other neonicotinoids were also detected in 72% of fruits and 45% of vegetables [10].
Active ingredients of neonicotinoids have been alleged as one of the factors that lead to the 
development of the honeybee colony collapse disorder syndrome [13, 14] and the decline of 
insectivorous birds [15]. Furthermore, although neonicotinoids have relatively low toxicity 
to mammals and humans compared with organophosphate and carbamate insecticides, in 
vitro and in vivo data suggest potential toxic effects of neonicotinoids on mammals, and 
even humans, including reproductive toxicology, neurotoxicity, immunotoxicity, 
hepatotoxicity/hepatocarcinogenicity, and genetic toxicity [16]. Long-term impacts of 
neonicotinoids on the environment are currently unknown and information on exposure to 
neonicotinoids in the US general population is not readily available even though human 
exposure may be on the rise because of increased use of these insecticides.
Neonicotinoids can be metabolized in mammals by phase I enzymes [17, 18]. Human 
cytochrome P450 recombinant enzymes convert thiamethoxam to clothianidin, clothianidin 
to desmethyl-clothianidin, and thiamethoxam to desmethyl-thiamethoxam [18]. Imidacloprid 
produces several in vitro metabolites [17]; 5-hydroxy-imidacloprid is one of the principal in 
vitro products [19]. Some of these phase I neonicotinoid metabolites can undergo phase II 
reactions such as glutathione conjugation, glycine conjugation, acetylation, and 
glucuronidation [20, 21] to facilitate elimination. There are currently no human in vivo 
metabolism studies; however, several neonicotinoids and some of their metabolites were 
identified in the urine of patients suspected of neonicotinoid pesticide poisoning [22, 23]. 
These included acetamiprid; N-desmethyl-acetamiprid; three imidacloprid metabolites: 5-
hydroxy-imidacloprid, 4,5-dehydro-imidacloprid, and 4,5-dihydroxy-imidacloprid; two 
clothianidin metabolites: N-desmethyl-clothianidin, N-(2-(methylsulfinyl) thiazole-5-
carboxyl)-glycine; and a common metabolite of acetemiprid and imidacloprid (N-(6-
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chloronicotinoyl)-glycine 4) [22, 23]. Some of these metabolites are potential biomarkers of 
human exposure.
Analytical methods using mass spectrometry for identifying and quantifying neonicotinoids 
and their metabolites in human urine are described in the literature and include GC-MS [24], 
GC-MS/MS [25], LC-TOFMS [23], LC-MS/MS-ESI [26–30], and UHPLC-Orbitrap MS 
[31].
N,N-Diethyl-m-toluamide, commonly known as DEET, is the principal ingredient in many 
personal insect repellents worldwide and is highly effective against potential disease vectors 
such as mosquitoes, biting flies, and ticks [32]. Every year, approximately one third of the 
US population uses DEET-containing insect repellents [33] and more than 500 products are 
currently registered with the U.S. Environmental Protection Agency in a variety of liquids, 
lotions, gels, sprays, sticks, and impregnated materials with DEET concentrations ranging 
from 5 to 99% [34]. In the US general population, exposure to DEET is widespread [35]. 
Identifying adequate metabolites as DEET exposure biomarkers is important because relying 
on DEET itself can lead to exposure misclassification [35, 36].
Reliable and accurate methods to obtain population exposure data for DEET and 
neonicotinoid insecticides are needed to better understand prevalence of exposure, and to 
evaluate whether exposure to these compounds may have any adverse effects on human 
health. In this paper, we describe an online solid-phase extraction high-performance liquid 
chromatography-isotope dilution tandem mass spectrometry (HPLC-MS/MS) method to 
quantify in 200 μL of urine the concentrations of six neonicotinoid biomarkers: acetamiprid, 
clothianidin, imidacloprid, thiacloprid, acetamiprid-N-desmethyl, and 5-hydroxy-
imidacloprid, and two DEET biomarkers: 3-diethyl-carbamoyl benzoic acid (DCBA) and 3-
ethyl-carbamoyl benzoic acid (ECBA).
Materials and methods
Reagents and chemicals
HPLC grade methanol, acetonitrile, and water were purchased from Fisher Scientific 
(Pittsburg, PA). Formic acid, acetamiprid, N-desmethyl-acetamiprid, thiacloprid, and 
thiacloprid-d4 were purchased from Fluka (Seelze, Germany). 4-Methylumbelliferone-13C4 
was purchased from Cambridge Isotope Laboratories, Inc. (Andover, MA). Phosphoric acid, 
β-glucuronidase (E. coli), imidacloprid, clothianidin-d3, imidacloprid-d4, and 4-
methylumbelliferyl-β-D-glucuronide hydrate were purchased from Sigma-Aldrich (St. 
Louis, MO). ECBA, DCBA, and acetamiprid-d5 were purchased from Cerilliant (Round 
Rock, TX). ECBA-d5, DCBA-d10, and N-desmethyl-acetamiprid-(2H, 13C, 15N2) were 
purchased from CanSyn Chemical Corporation (Toronto, Canada). Potassium phosphate 
dibasic trihydrate was purchased from MP Biomedicals (Santa Ana, CA). Clothianidin was 
purchased from Chemservice (West Chester, PA). 5-Hydro-imidacloprid-d4 was purchased 
from ClearSynth (Mississauga, ON, Canada). 5-Hydroxy-imidacloprid was a gift from Dr. 
Heiko Käfferlein of the Institute for Prevention and Occupational Medicine of the German 
Social Accident Insurance (Institute of the Ruhr-University, Bochum, Germany). Reagents, 
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solvents, and standard materials were used without additional purification. The chemical 
structures of the target analytes are shown in Fig. 1.
Human urine collection for method development and validation
Individual urine samples for method development and validation were collected in March of 
2017 in Atlanta, GA, from anonymous male and female donors with no documented 
exposure to DEET or neonicotinoids. A Human Subjects Institutional Review Board at The 
Centers for Disease and Control Prevention (CDC) reviewed and approved the collection 
protocol. A waiver of informed consent was requested under 45 CFR 16.116(d). Ten 
additional urine samples were purchased in May 2017 from BioIVT, Inc and 50 more in 
April 2018 to test the suitability of the method. The company had IRB approval to collect 
urine and obtained informed consent from donors. CDC’s use of the commercial urine was 
consistent with the IRB approval and donor consent. No personal identifiers were provided 
to CDC.
Preparation of native standard solutions, calibrators, internal standard spiking solution, 
and enzyme spiking solution
Stock solutions for native acetamiprid, N-desmethyl-acetamiprid, clothianidin, imidacloprid, 
and thiacloprid were purchased as certified solutions at 1 mg/mL in acetonitrile, except 
imidacloprid which was in acetone. Solutions for native DCBA, ECBA, and 5-hydroxy-
imidacloprid were made from powder dissolved in acetonitrile at 1 mg/mL, except ECBA, 
which was prepared at 0.1 mg/mL because of its inability to solubilize at higher 
concentrations. Individual stock solutions were combined in various proportions to prepare 
12 individual calibrator spiking solutions such that a 50-μL spike into 200 μL of deionized 
water resulted in concentrations ranging from 0.025 to 50.0 μg/L, except DCBA which had 
concentrations ranging from 0.12 to 250 μg/L.
Stable isotopically labeled analogs of all target analytes, except for 5-hydroxy-imidacloprid 
which used a surrogate for its internal standard (ISTD), were prepared at 1 mg/mL in 
acetonitrile. The stocks were combined and diluted with water resulting in an ISTD spiking 
solution such that a 100-μL spike into 200 μL of urine resulted in concentrations ranging 
from 12 to 50 μg/L, depending on the analyte. This ISTD spiking solution also contained 4-
methylumbelliferyl-β-D-glucuronide hydrate and 4-methylumbelliferone-13C4 at 
concentrations that resulted in 1 and 0.35 mg/L urine, respectively. For each sample, we 
monitored the deconjugated 4-methylumbelliferone/4-methylumbelliferone-13C4 peak area 
ratio to confirm completion of the enzymatic deconjugation reaction (ratio between 1.8 and 
2 based on spiked concentrations was considered acceptable).
An enzyme spiking solution was prepared weekly by gently dissolving β-glucuronidase in 
0.2 M potassium phosphate buffer (pH = 6.8 ± 0.1) such that a 300-μL spike in 200 μL of 
urine contained 1 Fishman unit per microliter of urine. The 0.2 M buffer solution was 
prepared in 1 L volumes and kept refrigerated for up to 2 months.
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Sample preparation
Samples were prepared for analysis in 96-well plates using a Tomtec Quadra 3 liquid 
handler (Hamden, CT, USA). To each well, 100 μL of ISTD spiking solution, 200 μL of 
urine, 300 μL of enzyme spiking solution, and 650 μL of HPLC grade water were added. 
Standard calibrators (S1-S12) had an additional 50 μL of standard spiking solution added. 
Plate contents were gently mixed on the Tomtec and incubated for 17 h at 37 °C. After 
incubation, 100 μL of 10% formic acid was added to each well. Following an additional mix 
on the Tomtec, plates were covered with pre-slit sealing mats and loaded into a 10 °C 
refrigerated autosampler for injection.
Online solid-phase extraction and analytical separation
We used a Thermo Scientific™ Dionex UltiMate™ 3000 Rapid Separation Dual HPLC 
system (Sunnyvale, CA, USA) consisting of (a) a DGP-3600RS module with dual 
independent operating Ternary Rapid Separation pumps, (b) an SRD-3600 Integrated 
Solvent and Degasser rack, (c) a WPS-3000TRS temperature-controlled autosampler, and 
(d) a TCC-3000RS column thermostat compartment equipped with one six-port switching 
valve. The first pump was dedicated to online solid-phase extraction (SPE) and we refer to it 
as the SPE pump. The second pump was used for analytical separation and we refer to it 
here as the analytical pump. We used a Chromolith Flash RP-18e monolithic 25 × 4.6 mm 
(EMD Chemicals, Gibbstown, NJ) as the SPE column and a Thermo Scientific™ Hypersil 
Gold aQ column 150 × 4.6 mm, 3 μm particle size, with guard column of the same packing, 
as the analytical column. The SPE pump mobile phase A was 5% methanol in 0.1% aqueous 
formic acid, and mobile phase B was 100% methanol. The analytical pump mobile phase A 
was 0.1% aqueous formic acid, and mobile phase B was 100% acetonitrile.
To isolate the target compounds, the online SPE method used a three-step process: SPE 
loading/washing, SPE eluting, and analytical chromatographic separation. Flow rates and 
valve switching times are shown in Fig. 2. A diagram is shown in Electronic Supplementary 
Material (ESM, Fig. S1). Briefly, in step 1 (SPE loading), 500 μL is injected into the SPE 
column using the SPE pump. The SPE pump washes the SPE column with 100% A at 1 
mL/min for 0.4 min then immediately increases the flow to 2 mL/min for two additional 
minutes and then flow is stopped. At 2.5 min, the switching valve is activated initiating step 
2 (SPE eluting). Switching of the valve reroutes the analytical pump’s flow (25% B at 1 mL/
min) through the SPE column in a reverse direction and in line with the analytical column. 
After 1 min, all target analytes completely elute onto the analytical column and the 
switching valve returns to its initial load/wash position. In step 3 (analytical 
chromatographic separation), the analytical pump begins a gradient at 4 min from 25% B to 
50% B ending at 8 min and then back to 25% B at 8.1 min. All target analytes elute from the 
analytical column between 6 and 9 min. From 5.2 to 8.5 min, the SPE pump independently 
washes the SPE cartridge with 100% B at 3 mL/min and then equilibrates the SPE column 
with 100% A from 8.6–11 min at 1 mL/min, making it ready for the next injection.
Mass spectrometer settings
We used a Thermo Scientific Vantage triple quadrupole (TSQ) mass spectrometer (San Jose, 
CA, USA) equipped with a Heated Electrospray Ionization (HESI) probe. The HESI probe 
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used the following settings: spray voltage (3200 V), vaporizer temperature (500 °C), sheath 
gas flow rate (50 arbitrary units [AU]), sweep gas flow rate (1.0 AU), auxiliary gas flow rate 
(5 AU), and capillary temperature (400 °C). Nitrogen was used as sheath, sweep, and 
auxiliary gas. Argon was used as the collision gas at 1.5 mTorr. The mass spectrometer 
operated in positive polarity selected reaction monitoring (SRM) mode, with a scan time of 
0.06 s for each ion transition. Table 1 shows the mass transitions and collision energies for 
each compound of interest.
Daily operation and quality control procedures
Quality control (QC) materials were prepared from a urine pool obtained from multiple 
anonymous donors. The pool was divided into two sub pools that were enriched with native 
target analytes to create low-concentration (QCL, 4–10 μg/L) and high-concentration (QCH, 
16–90 μg/L) QC materials. The two pools were mixed overnight at 5 °C, dispensed in 2-mL 
portions in polypropylene vials, and stored long term at − 70 °C and up to 12 weeks at 
− 20 °C. Each QC material was characterized by repeated measurements to define mean 
concentrations and 95% and 99% control limits of each target analyte.
An analytical run included 12 calibration standards, two reagent blanks, four QC materials 
(2 QCL and 2 QCH), and up to 72 study samples. A standard check was analyzed at the 
beginning of each analytical run, to confirm acceptable chromatographic retention time and 
shape, and mass spectrometry sensitivity. Raw data from the analytical run were integrated 
using Xcalibur 2.2 software (Thermo Scientific, San Jose, CA) and transferred to a database 
where data were checked against previously established values and flagged, if not 
acceptable, for example, LOD values, standard curve y-intercept values, quantification and 
confirmation concentration difference, internal standard area count, and relative retention 
time. Samples outside acceptable ranges were re-extracted and reanalyzed. Samples with 
results above the calibration curve were re-extracted with a smaller sample volume. QCL 
and QCH data were statistically analyzed applying modified Westgard QC rules [37] using 
SAS (SAS Institute Inc., Cary, NC) to ensure statistical control of the analytical run.
Method validation
Precision was determined by measuring two replicates of the two QC urine pools (low and 
high concentrations). Pools were analyzed in 25 analytical runs over 2 months using two 
identical analytical systems and two different analysts. Precision was expressed as percent 
relative standard deviation (%RSD). Mean and standard deviations were used to determine 
quality control limits used in analyzing 60 test samples.
Because certified reference materials were not available for the target analytes, we 
determined accuracy and selectivity by spiked recovery (measured concentration / known 
concentration × 100). We spiked 20 individual urine samples with known concentrations 
(low, medium, and high) of native analytes. Measured concentrations were corrected for any 
endogenous amount of the target compounds, if applicable, by subtracting the blank 
measured concentration. The accuracy was expressed as the average of the 20 spiked 
recovery values. The acceptable range for accuracy was 85 to 115% [38]. Selectivity was 
Baker et al. Page 6
Anal Bioanal Chem. Author manuscript; available in PMC 2019 August 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
indirectly evaluated using the spiked recovery data. The reasoning was that if the results 
were accurate, the method used must also be selective [39].
The limit of detection (LOD) was determined using 25 repeat measurements of low-
concentration standards spiked in urine. For each analyte, from a plot of the standard 
deviation of the 25 measured values at each concentration versus the spiked concentrations, 
we determined the y-intercept (S0, standard deviation at zero concentration) using linear 
regression analysis. We calculated LODs as 3 times S0 [40]. Linearity was evaluated by 
performing both linear and quadratic regressions over several standard curves and by 
analyzing residual plots.
Stability of the target analytes was evaluated in both water and urine. Stability in water was 
determined by aliquotting 400 μL of a 25 μg/L solution of the combined native compounds 
into clear silanized 2-mL screw-capped vials and storing them at − 70, − 20, 5, 25, and 
37 °C. The ISTD spiking solution was stored at − 70 °C. Aliquots stored at 25 °C were also 
dispensed into amber vials to test for potential degradation from ultraviolet light. The vials 
stored at 25 °C remained on a lab benchtop under room light for the duration of the testing 
period. Periodically, over 120 days, a vial from each temperature location was removed 
along with a vial of ISTD and brought to room temperature. One hundred microliters of the 
native solution and 50 μL of ISTD were added to silanized vials in triplicate, vortex mixed, 
and analyzed. Plots of the responses (native/ISTD) versus time were used to evaluate 
possible degradation. Because the ISTD stored at − 70 °C was assumed to be stable, a 
negative slope was interpreted as possible degradation of the native.
Stability of response ratios (native/ISTD) was also tested in water at 37 °C by adding target 
compounds and their respective ISTDs into water. Twenty-one samples were prepared in 
silanized vials. Three vials were analyzed immediately (time zero). The remaining 18 
samples were placed in a 37 °C oven. Periodically, throughout a 34-h time period, three vials 
were removed and analyzed. Regression analysis was applied to plots of response ratios 
versus time spent at 37 °C. From the linear regression equations, a percent gain or loss in 
response factors over a 17-h period was calculated. A zero slope indicated that native and 
ISTD had the same thermal stability characteristics.
Stability of the target analytes in urine was determined using two urine pools, spiked at low 
and high concentrations. Pools were analyzed in triplicate before and after (a) three freeze-
thaw cycles, (b) being kept on the lab bench for 24 h, and (c) prepared urine samples were 
left in the autosampler kept at 10 °C for 24 h. Percent differences of the before and after 
measured values were determined, with ± 15% being acceptable [38].
Relative matrix effects were evaluated by measuring the variability of standard curve slopes 
prepared in five individual urine specimens as recommended by Matuszewski [41]. For each 
individual urine, a standard curve was prepared and analyzed every day for 5 days, the 
resulting five slopes from each individual urine were averaged, and the percent RSD of the 
averaged slopes was calculated. Values < 3–4% indicated that the internal standard was 
effective at correcting for relative matrix effects [41].
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Results and discussion
SPE/analytical columns selection
We evaluated several online SPE columns including Sunfire® C8 5 μm, Sunfire® C18 5 μm, 
Waters XSelect™ HHS PFP 5 μm, Waters XSelect® CSH™ Fluoro-Phenyl 5 μm, Waters 
Oasis® HLB 5 μm, and Chromolith Flash RP-18e monolithic 25 × 4.6 mm. The Waters 
Oasis® HLB performed adequately and has recently been used for the quantification of 
several neonicotinoid biomarkers [31]. Nevertheless, we chose the Chromolith Flash RP-18e 
because, under our experimental conditions, it provided the cleanest background and fewest 
chromatographic interferences. The target compounds eluted from the SPE column in less 
than 1 min with 25% acetonitrile, and effectively refocused on a ThermoScientific Hypersyl 
GOLD™ aQ polar encapped analytical column. We chose the analytical column primarily 
because it produced the sharpest and narrowest peaks of all columns tested (analytical peak 
widths were approximately 15 s, Fig. 3). All target compounds eluted between 6 and 9 min.
Method validation
Precision, accuracy (spike recovery), and LOD parameters are summarized in Table 3. 
Precision (%RSD) ranged from 3.7 to 10.2%. Precision was < 8% for all analytes except 5-
hydroxy-imidacloprid (9.2% [QCL], 10.2% [QCH]). Accuracy ranged from 91.2 to 107% at 
the low concentration, from 93.2 to 116% at the medium concentration, and from 94.8 to 
114% at the high concentration (Table 3), all within the 85 to 115% acceptable range [38], 
except for 5-hydroxy-imidacloprid at the medium concentration level. The acceptable 
accuracy data also support the selectivity of the method [38, 39]. Compared to the other 
analytes, we attribute the lower accuracy of 5-hydroxy-imidacloprid (107, 116, and 114% at 
the low, medium, and high concentrations, respectively) and precision (~ 10%) to not having 
an exact isotopically labeled analog, which was not commercially available at the time. 
Therefore, we used a surrogate ISTD which had the OH functional group on the 5 position 
of the 6-chloro-3-pyridinyl moiety instead of the 5 position of the 1H-imidazol moiety. This 
surrogate ISTD eluted about 20 s earlier than the native 5-hydroxy-imidacloprid, which 
likely further contributed to reducing its effectiveness to compensate for matrix effects and 
to a concomitant loss in accuracy and precision.
The LODs ranged from 0.01 to 0.1 μg/L (Table 2). These values are similar to those reported 
before [26–29, 31, 42, 43] and adequate for quantification of these biomarkers at trace 
levels.
Quadratic regressions showed no statistical significance (p > 0.05) for the squared term. 
Linear regressions of standard curves from 15 runs on 15 different days for all analytes 
produced R-squared values > 0.98 (range, 0.9837 to 0.9976) and were linear over 2.5 orders 
of magnitude. Residual plots for all analytes were acceptable.
The stability of the DEET and neonicotinoid biomarkers in human urine and water was 
assessed under several storage/ handling conditions. At 25 °C, there were no differences in 
the degradation curves associated with storing the analytes in amber versus clear vials. In 
deionized water, we observed degradation of 5-hydroxy-imidacloprid at 25 °C and 37 °C, 
and, to a lesser degree, of acetamiprid, but only at 37 °C. We estimate that native 5-hydroxy-
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imidacloprid and acetamiprid concentrations decreased about 9% and 6%, respectively, after 
17 h at 37 °C. However, the method was still accurate for two main reasons. First, each 
analytical run included a standard curve which underwent the exact same treatment as the 
samples being analyzed. Any bias caused by degradation of the native or ISTD in the 
samples being analyzed was offset by the same thermal degradation occurring in the native 
or ISTD of the standard calibrators. Second, with the exception of 5-hydroxy-imidacloprid, 
the method used stable isotopically labeled analogs as ISTDs which theoretically behaved as 
their unlabeled counterparts. The response ratios for each analyte in the test samples stored 
for 17 h at 37 °C varied less than 2% for all analytes except for 5-hydroxy-imidacloprid, 
which decreased about 7%.
Stability of target analytes in urine showed percent differences in measured amounts below 
± 15% for all analytes at both low and high levels except one value for 5-
hydroxyimidacloprid which had a percent difference of − 16% for the high pool. The larger 
variability for 5-hydroxyimidacloprid was likely caused by the lack of an exact stable 
isotopically labeled analog.
Relative matrix effects were negligible for most analytes as indicated by the %RSD of the 
averaged slopes (0.9 to 3.3%), suggesting no negative impact on method performance [41]. 
The higher %RSD for 5-hydroxy-imidacloprid (10.5%) was likely the result of the 
unavailability of a stable isotopically labeled analog. The low RSD values for the other 
seven analytes stress the importance and effectiveness of using stable isotopically labeled 
analogs as ISTDs to greatly reduce or eliminate relative matrix effects [41].
Method application
We detected the DEET metabolites in most of the 60 commercial samples analyzed (DCBA, 
95%; ECBA, 83%) (Table 3). Furthermore, concentrations of DCBA and ECBA strongly 
correlated (R2 = 0.983). These results suggest widespread exposure to DEET in these 
convenience samples and are in agreement with data from the 2007–2014 National Health 
and Nutrition Examination Survey (NHANES) showing that DCBA was detected in most 
US residents over the 8-year timespan [44]. Furthermore, because DCBA is a known 
biomarker of exposure to DEET [35], the strong correlation between DCBA and ECBA 
suggests that ECBA is also an acceptable urinary biomarker of DEET. The most commonly 
detected neonicotinoid biomarkers were N-desmethyl-acetamiprid (90%), 5-hydroxy-
imidacloprid (42%), clothianidin (37%), and imidacloprid (30%). Acetamiprid was detected 
in 2% of the samples, and thiacloprid was not detected in any. These data suggest that 
neonicotinoid metabolites are better biomarkers than the parent compounds themselves.
Conclusions
We present a sensitive, accurate, and precise high-throughput method for quantifying trace 
concentrations of DEET and neonicotinoid biomarkers in human urine using online SPE and 
isotope dilution HPLC-MS/MS. Our results confirm the applicability of the method for 
biomonitoring purposes to evaluate human exposure to DEET and neonicotinoids and 
suggest that neonicotinoid and neonicotinoid metabolites can serve as biomarkers of 
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exposure. We plan to use the method to obtain reference ranges for these pesticides 
biomarkers in large-scale epidemiological studies such as NHANES.
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Fig. 1. 
Chemical structures of two oxidative metabolites of DEET, 3-diethyl-carbamoyl benzoic 
acid (DCBA) and 3-ethyl-carbamoyl benzoic acid (ECBA); four neonicotinoid insecticides: 
acetamiprid, clothianidin, imidacloprid, and thiacloprid; and two neonicotinoid metabolites: 
N-desmethyl-acetamiprid and 5-hydroxy-imidacloprid
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Fig. 2. 
Valve positions, SPE and analytical pumps timing chart, and solvent conditions
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Fig. 3. 
Extracted ion chromatogram of an analytical standard in urine diluted 1:1 with HPLC grade 
water. Concentrations are given for each analyte
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